D
Context Therapeutics Inc. CNTX
$0.8595 -$0.0134-1.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 13.13% 11.67% 9.85% 10.67% -6.96%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 215.96% 44.61% -37.83% 202.59% -41.64%
Operating Income -215.96% -44.61% 37.83% -202.59% 41.64%
Income Before Tax -291.55% -24.80% 50.62% -197.20% 55.01%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -291.55% -24.80% 50.62% -197.20% 55.01%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -291.55% -24.80% 50.62% -197.20% 55.01%
EBIT -215.96% -44.61% 37.83% -202.59% 41.64%
EBITDA -216.08% -44.60% 37.85% -202.69% 41.65%
EPS Basic -126.10% 79.06% 90.38% 41.04% 86.94%
Normalized Basic EPS -126.56% 79.04% 90.38% 41.04% 86.95%
EPS Diluted -126.10% 79.06% 80.33% 41.04% 86.94%
Normalized Diluted EPS -126.56% 79.04% 90.38% 41.04% 86.95%
Average Basic Shares Outstanding 73.20% 496.18% 413.15% 404.07% 244.22%
Average Diluted Shares Outstanding 73.20% 496.18% 413.15% 404.07% 244.22%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --